[Do anti-inflammatory drugs worsen odontogenic cervico-facial cellulitis?]

Rev Stomatol Chir Maxillofac Chir Orale. 2013 Nov;114(5):304-9. doi: 10.1016/j.revsto.2013.07.011. Epub 2013 Aug 27.
[Article in French]

Abstract

Objective: The aim of this prospective study was to determine the influence of anti-inflammatory drugs on the severity of odontogenic cellulitis in patients admitted to our hospital emergency unit.

Study design: The study was made from April 30 to October 31 2006. The clinical and pharmacological data was prospectively collected at admission, during hospitalization, and during systematic follow-up. We first studied the whole population and then compared the two groups: patients having received anti-inflammatory drugs before admission or not.

Results: Two hundred and sixty-seven patients were included. The only severity criterion significantly different between the two groups was spreading of cervical lymphangitis (P = 0.028). None of the four studied parameters was identified as a risk factor for spreading of cervical lymphangitis in multivariate analysis: anti-inflammatory use (OR = 5.99, 95%CI [0.71-50.88]), alcohol abuse (OR = 4.00, 95%CI [0.66-24.12]), dental hygiene (OR = 1.53, 95%CI [0.36-6.56]), and tobacco use (OR = 0.27, 95%CI [0.57-1.28]).

Discussion: The use of anti-inflammatory drugs during the initial phase of an odontogenic infection was not related to the severity of infection.

Keywords: Anti-inflammatoires; Anti-inflammatory agent; Cellulite; Cellulitis; Infection.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Anti-Inflammatory Agents / therapeutic use*
  • Cellulitis / epidemiology
  • Cellulitis / etiology*
  • Cellulitis / therapy
  • Face
  • Female
  • Humans
  • Length of Stay / statistics & numerical data
  • Male
  • Middle Aged
  • Neck
  • Patient Admission / statistics & numerical data
  • Stomatognathic Diseases / complications*
  • Stomatognathic Diseases / epidemiology
  • Stomatognathic Diseases / therapy
  • Young Adult

Substances

  • Anti-Inflammatory Agents